Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Oxycodone | 3 | 2020 | 138 | 1.760 |
Why?
|
Narcotics | 2 | 2020 | 336 | 1.100 |
Why?
|
Self Stimulation | 3 | 2014 | 47 | 0.810 |
Why?
|
Prosencephalon | 2 | 2014 | 305 | 0.790 |
Why?
|
Limbic System | 2 | 2014 | 419 | 0.760 |
Why?
|
Lithium Chloride | 2 | 2013 | 82 | 0.750 |
Why?
|
Conditioning, Operant | 2 | 2010 | 308 | 0.590 |
Why?
|
Nucleus Accumbens | 1 | 2019 | 365 | 0.540 |
Why?
|
Sucrose | 1 | 2017 | 156 | 0.540 |
Why?
|
Morphine | 1 | 2020 | 653 | 0.540 |
Why?
|
Self Administration | 4 | 2020 | 390 | 0.510 |
Why?
|
Sweetening Agents | 1 | 2017 | 290 | 0.470 |
Why?
|
Behavior, Addictive | 1 | 2019 | 462 | 0.440 |
Why?
|
Naphthalenes | 2 | 2014 | 198 | 0.440 |
Why?
|
Benzoxazines | 2 | 2014 | 309 | 0.410 |
Why?
|
Dextroamphetamine | 2 | 2010 | 134 | 0.410 |
Why?
|
Rats, Sprague-Dawley | 9 | 2020 | 8144 | 0.400 |
Why?
|
Drug Tolerance | 1 | 2013 | 367 | 0.400 |
Why?
|
Dopamine Agonists | 1 | 2014 | 352 | 0.390 |
Why?
|
Morpholines | 2 | 2014 | 580 | 0.370 |
Why?
|
Synaptic Transmission | 1 | 2014 | 1168 | 0.300 |
Why?
|
Rats | 8 | 2020 | 23681 | 0.290 |
Why?
|
Calcium Channel Blockers | 1 | 2010 | 694 | 0.270 |
Why?
|
Quinolones | 1 | 2010 | 377 | 0.270 |
Why?
|
Receptor, Melanocortin, Type 3 | 2 | 2017 | 12 | 0.270 |
Why?
|
Reward | 2 | 2013 | 965 | 0.270 |
Why?
|
Indoles | 1 | 2014 | 1828 | 0.260 |
Why?
|
Behavior, Animal | 4 | 2019 | 1867 | 0.260 |
Why?
|
Receptors, Dopamine D2 | 3 | 2019 | 485 | 0.260 |
Why?
|
Opioid-Related Disorders | 1 | 2020 | 2142 | 0.260 |
Why?
|
Receptors, Ghrelin | 2 | 2015 | 20 | 0.250 |
Why?
|
Agouti-Related Protein | 2 | 2017 | 93 | 0.250 |
Why?
|
Antimanic Agents | 1 | 2008 | 520 | 0.240 |
Why?
|
MicroRNAs | 1 | 2019 | 3783 | 0.210 |
Why?
|
Antipsychotic Agents | 2 | 2013 | 3060 | 0.210 |
Why?
|
Receptors, AMPA | 2 | 2014 | 322 | 0.200 |
Why?
|
Emotions | 1 | 2014 | 2734 | 0.200 |
Why?
|
Motor Activity | 3 | 2014 | 2686 | 0.180 |
Why?
|
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 2019 | 20 | 0.170 |
Why?
|
Tetrahydroisoquinolines | 1 | 2019 | 81 | 0.170 |
Why?
|
Piperazines | 1 | 2010 | 2511 | 0.160 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 2 | 2014 | 892 | 0.160 |
Why?
|
Microinjections | 1 | 2019 | 321 | 0.160 |
Why?
|
Receptors, Opioid, kappa | 1 | 2019 | 138 | 0.160 |
Why?
|
Pyrrolidines | 1 | 2019 | 337 | 0.150 |
Why?
|
Receptors, Dopamine D1 | 2 | 2015 | 293 | 0.140 |
Why?
|
Reinforcement Schedule | 1 | 2017 | 123 | 0.140 |
Why?
|
Anti-Anxiety Agents | 1 | 2019 | 397 | 0.140 |
Why?
|
Electric Stimulation | 2 | 2013 | 1732 | 0.140 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2019 | 370 | 0.130 |
Why?
|
Appetite | 2 | 2017 | 247 | 0.130 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2014 | 10747 | 0.130 |
Why?
|
Neuropeptide Y | 1 | 2017 | 191 | 0.130 |
Why?
|
Frontal Lobe | 1 | 2022 | 1419 | 0.130 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2020 | 623 | 0.130 |
Why?
|
Neurons | 2 | 2017 | 9418 | 0.120 |
Why?
|
Animals | 13 | 2020 | 167777 | 0.120 |
Why?
|
Narcotic Antagonists | 1 | 2019 | 583 | 0.120 |
Why?
|
Dependovirus | 1 | 2019 | 711 | 0.110 |
Why?
|
Benzamides | 1 | 2019 | 1368 | 0.110 |
Why?
|
Receptor, Cannabinoid, CB1 | 1 | 2014 | 137 | 0.110 |
Why?
|
Receptors, Dopamine D3 | 1 | 2014 | 108 | 0.110 |
Why?
|
Exploratory Behavior | 1 | 2014 | 273 | 0.110 |
Why?
|
Bipolar Disorder | 1 | 2010 | 5083 | 0.100 |
Why?
|
Maze Learning | 1 | 2014 | 477 | 0.100 |
Why?
|
Infusions, Intravenous | 1 | 2017 | 2210 | 0.100 |
Why?
|
Basal Ganglia | 1 | 2014 | 552 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2014 | 585 | 0.100 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2013 | 490 | 0.090 |
Why?
|
Schizotypal Personality Disorder | 1 | 2012 | 290 | 0.090 |
Why?
|
Nerve Tissue Proteins | 2 | 2014 | 4406 | 0.090 |
Why?
|
Piperidines | 1 | 2019 | 1639 | 0.090 |
Why?
|
Analysis of Variance | 2 | 2010 | 6233 | 0.090 |
Why?
|
Central Nervous System Stimulants | 2 | 2010 | 1176 | 0.090 |
Why?
|
Disease Models, Animal | 1 | 2010 | 18125 | 0.090 |
Why?
|
Protein Subunits | 1 | 2013 | 942 | 0.090 |
Why?
|
Medial Forebrain Bundle | 1 | 2010 | 43 | 0.090 |
Why?
|
Genetic Vectors | 1 | 2019 | 3380 | 0.080 |
Why?
|
Brain | 2 | 2022 | 26951 | 0.080 |
Why?
|
Personality | 1 | 2012 | 552 | 0.080 |
Why?
|
Drug Administration Routes | 1 | 2008 | 150 | 0.080 |
Why?
|
Neuronal Plasticity | 2 | 2015 | 1429 | 0.080 |
Why?
|
Biophysics | 1 | 2010 | 380 | 0.080 |
Why?
|
Energy Metabolism | 2 | 2017 | 2868 | 0.080 |
Why?
|
Sensory Thresholds | 1 | 2010 | 377 | 0.080 |
Why?
|
Cytoskeletal Proteins | 1 | 2014 | 1342 | 0.080 |
Why?
|
Dopamine | 1 | 2015 | 1599 | 0.080 |
Why?
|
Male | 12 | 2020 | 358742 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2019 | 2980 | 0.080 |
Why?
|
Parent-Child Relations | 1 | 2012 | 759 | 0.070 |
Why?
|
Antidepressive Agents | 1 | 2019 | 2889 | 0.070 |
Why?
|
Locomotion | 1 | 2010 | 387 | 0.070 |
Why?
|
Gene Expression Profiling | 1 | 2022 | 9405 | 0.070 |
Why?
|
Parenting | 1 | 2012 | 695 | 0.070 |
Why?
|
Valproic Acid | 1 | 2008 | 442 | 0.070 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 1972 | 0.060 |
Why?
|
Drug Interactions | 1 | 2010 | 1414 | 0.060 |
Why?
|
Aging | 1 | 2022 | 8651 | 0.060 |
Why?
|
Sex Factors | 1 | 2017 | 10505 | 0.050 |
Why?
|
Drug Combinations | 1 | 2008 | 2020 | 0.050 |
Why?
|
Phosphorylation | 1 | 2013 | 8297 | 0.050 |
Why?
|
RNA, Messenger | 2 | 2014 | 12760 | 0.050 |
Why?
|
Anxiety Disorders | 1 | 2012 | 2714 | 0.050 |
Why?
|
Stress, Psychological | 1 | 2014 | 4457 | 0.040 |
Why?
|
Anxiety | 1 | 2012 | 4538 | 0.040 |
Why?
|
Photoperiod | 1 | 2017 | 139 | 0.030 |
Why?
|
Homeostasis | 2 | 2017 | 3302 | 0.030 |
Why?
|
Darkness | 1 | 2014 | 158 | 0.030 |
Why?
|
Food Deprivation | 1 | 2014 | 114 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2019 | 1335 | 0.030 |
Why?
|
Injections, Intraperitoneal | 1 | 2014 | 412 | 0.030 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 1 | 2014 | 415 | 0.030 |
Why?
|
Signal Transduction | 1 | 2015 | 23341 | 0.030 |
Why?
|
Hypothalamus | 1 | 2017 | 998 | 0.020 |
Why?
|
Receptors, GABA-A | 1 | 2014 | 621 | 0.020 |
Why?
|
Female | 2 | 2020 | 390316 | 0.020 |
Why?
|
Object Attachment | 1 | 2012 | 326 | 0.020 |
Why?
|
Personality Inventory | 1 | 2012 | 1018 | 0.020 |
Why?
|
Energy Intake | 1 | 2017 | 2127 | 0.020 |
Why?
|
Memory | 1 | 2015 | 2179 | 0.020 |
Why?
|
Body Composition | 1 | 2014 | 2416 | 0.020 |
Why?
|
Hippocampus | 1 | 2015 | 3736 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2015 | 18942 | 0.010 |
Why?
|
Genotype | 1 | 2014 | 12945 | 0.010 |
Why?
|
Humans | 2 | 2022 | 758381 | 0.010 |
Why?
|
Mice | 2 | 2017 | 81107 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2014 | 14354 | 0.010 |
Why?
|
Parents | 1 | 2012 | 3548 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2014 | 22006 | 0.010 |
Why?
|
Time Factors | 1 | 2014 | 39873 | 0.010 |
Why?
|
Adolescent | 1 | 2012 | 87888 | 0.000 |
Why?
|
Adult | 1 | 2012 | 219916 | 0.000 |
Why?
|
Concepts
(132)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_